Y H Shaib1, J A Davila, H B El-Serag. 1. Section of Health Services Research, Michael E. Debakey Veterans Affairs Medical Center, Houston, TX 77030, USA. yshaib@bcm.tmc.edu
Abstract
BACKGROUND: Pancreatic cancer is the fourth leading cause of cancer death in the United States. AIM: To examine temporal changes in the incidence and survival of patients with pancreatic adenocarcinoma. METHODS: Using data from nine registries of the Surveillance, Epidemiology and End Results programme, age-adjusted incidence rates per 100 000 and survival rates were calculated for pancreatic cancer between 1977 and 2001. RESULTS: We identified 58 655 cases of pancreatic cancer. The age-adjusted incidence rate remained stable during the study period (11.3 in 1977-1981 and 10.9 in 1997-2001). Overall, men were 30% more affected than women (age-adjusted incidence rate of 13.0 in men and 9.8 in women). The age-adjusted incidence rates were almost 50% higher among Blacks (16.4) than Whites (10.8) and people of other races (9.8). Over time the proportions of patients with localized disease decreased from 12.3% to 7.4% and those with regional disease increased from 18.6% to 25.8%, while metastatic disease remained stable (52.5% vs. 49.8%). The 1-year relative survival increased from 15.2% in 1977-1981 to 21.6% in 1997-2001. CONCLUSIONS: The incidence of pancreatic cancer is stable. A shift from localized to regional disease was observed over time. The overall survival remains poor despite important improvements among patients with early stage disease.
BACKGROUND:Pancreatic cancer is the fourth leading cause of cancer death in the United States. AIM: To examine temporal changes in the incidence and survival of patients with pancreatic adenocarcinoma. METHODS: Using data from nine registries of the Surveillance, Epidemiology and End Results programme, age-adjusted incidence rates per 100 000 and survival rates were calculated for pancreatic cancer between 1977 and 2001. RESULTS: We identified 58 655 cases of pancreatic cancer. The age-adjusted incidence rate remained stable during the study period (11.3 in 1977-1981 and 10.9 in 1997-2001). Overall, men were 30% more affected than women (age-adjusted incidence rate of 13.0 in men and 9.8 in women). The age-adjusted incidence rates were almost 50% higher among Blacks (16.4) than Whites (10.8) and people of other races (9.8). Over time the proportions of patients with localized disease decreased from 12.3% to 7.4% and those with regional disease increased from 18.6% to 25.8%, while metastatic disease remained stable (52.5% vs. 49.8%). The 1-year relative survival increased from 15.2% in 1977-1981 to 21.6% in 1997-2001. CONCLUSIONS: The incidence of pancreatic cancer is stable. A shift from localized to regional disease was observed over time. The overall survival remains poor despite important improvements among patients with early stage disease.
Authors: David P Horowitz; Charles C Hsu; Jingya Wang; Martin A Makary; Jordan M Winter; Ray Robinson; Richard D Schulick; John L Cameron; Timothy M Pawlik; Joseph M Herman Journal: Int J Radiat Oncol Biol Phys Date: 2010-07-17 Impact factor: 7.038
Authors: Israel Vlodavsky; Phillip Beckhove; Immanuel Lerner; Claudio Pisano; Amichai Meirovitz; Neta Ilan; Michael Elkin Journal: Cancer Microenviron Date: 2011-08-03
Authors: M Castañeda-Avila; C R Torres-Cintrón; A Cruz-Benítez; W Fuentes-Payán; A Maldonado-Albertorio; L Nieves-Ferrer; P Padró-Juarbe; R Soto-Abreu; N Perez-Ríos; K J Ortiz-Ortiz; P Magno; A P Ortiz Journal: P R Health Sci J Date: 2019-09 Impact factor: 0.705
Authors: Stephen Y Oh; Alicia Edwards; Margaret T Mandelson; Bruce Lin; Russell Dorer; W Scott Helton; Richard A Kozarek; Vincent J Picozzi Journal: World J Gastroenterol Date: 2015-12-28 Impact factor: 5.742